Pay in 4 interest-free payments of $5.84 Learn more
Ships within 48 hours · Estimated delivery Aug 25 - Aug 30
Thus, despite FDA announcing the end of the GLP-1 drug shortage in March 2025 and setting May 22 as the last day when compounded versions could be sold, the large-scale production of compounded GLP-1s continues unabated
However, as the drug is unlicensed, these trial doses do not constitute an approved dosing regimen for general use
(2026, February 26)
Plan Your Retatrutide Schedule Enter any dose, split frequency, and vial concentration
Research Injectable: Typically administered via subcutaneous (SubQ) injection
US$ 20.33
US$ 22.64
US$ 29.76
US$ 22.55
US$ 29.23
US$ 20.44
US$ 26.21
